Moreover, a good response to interleukin (IL)-1β inhibitors and IL-18 binding protein observed in AOSD patients [7,8] suggests a critical role of NLRP3-inflammasome signaling in its pathogenesis. Here, NLRP3 is linked to adult-onset Still disease.